0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hirudin Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-8X2673
Home | Market Reports | Health
COVID 19 Impact on Global Hirudin Market Insights Forecast to 2026
BUY CHAPTERS

Global Hirudin Market Research Report 2026

Code: QYRE-Auto-8X2673
Report
2026-02-05
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hirudin Market Size

The global Hirudin market was valued at US$ 4341 million in 2025 and is anticipated to reach US$ 5359 million by 2032, at a CAGR of 3.1% from 2026 to 2032.

Hirudin Market

Hirudin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hirudin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin’s applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.
The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.
However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.
In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.
This report delivers a comprehensive overview of the global Hirudin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hirudin. The Hirudin market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hirudin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hirudin manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hirudin Market Report

Report Metric Details
Report Name Hirudin Market
Accounted market size in 2025 US$ 4341 million
Forecasted market size in 2032 US$ 5359 million
CAGR 3.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Natural Hirudin
  • Recombinant Hirudin
by Application
  • Thrombosis Disease
  • Tumor Disease
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Teva Pharmaceuticals, Pfizer, Inc, Pentapharm, DUOPUTAI, Abbott, Keyken, Minapharm, Salubris Bio, Hoechst AG, Ciba-Geigy, Boehringer Ingelheim, Sanofi, Xellia Pharmaceuticals, Haplogen Pharmaceuticals, Shenzhen Kangtai Biological, Dong-A ST
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hirudin manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Hirudin production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Hirudin consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hirudin Market growing?

Ans: The Hirudin Market witnessing a CAGR of 3.1% during the forecast period 2026-2032.

What is the Hirudin Market size in 2032?

Ans: The Hirudin Market size in 2032 will be US$ 5359 million.

Who are the main players in the Hirudin Market report?

Ans: The main players in the Hirudin Market are Novartis, Teva Pharmaceuticals, Pfizer, Inc, Pentapharm, DUOPUTAI, Abbott, Keyken, Minapharm, Salubris Bio, Hoechst AG, Ciba-Geigy, Boehringer Ingelheim, Sanofi, Xellia Pharmaceuticals, Haplogen Pharmaceuticals, Shenzhen Kangtai Biological, Dong-A ST

What are the Application segmentation covered in the Hirudin Market report?

Ans: The Applications covered in the Hirudin Market report are Thrombosis Disease, Tumor Disease, Others

What are the Type segmentation covered in the Hirudin Market report?

Ans: The Types covered in the Hirudin Market report are Natural Hirudin, Recombinant Hirudin

1 Hirudin Market Overview
1.1 Product Definition
1.2 Hirudin by Type
1.2.1 Global Hirudin Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Hirudin by Application
1.3.1 Global Hirudin Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Hirudin Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Hirudin Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Hirudin Production Estimates and Forecasts (2021–2032)
1.4.4 Global Hirudin Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Hirudin Production Market Share by Manufacturers (2021–2026)
2.2 Global Hirudin Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Hirudin, Industry Ranking, 2024 vs 2025
2.4 Global Hirudin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Hirudin Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Hirudin, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Hirudin, Product Offerings and Applications
2.8 Global Key Manufacturers of Hirudin, Date of Entry into the Industry
2.9 Hirudin Market Competitive Situation and Trends
2.9.1 Hirudin Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Hirudin Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Hirudin Production by Region
3.1 Global Hirudin Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Hirudin Production Value by Region (2021–2032)
3.2.1 Global Hirudin Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Hirudin by Region (2027–2032)
3.3 Global Hirudin Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Hirudin Production Volume by Region (2021–2032)
3.4.1 Global Hirudin Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Hirudin by Region (2027–2032)
3.5 Global Hirudin Market Price Analysis by Region (2021–2026)
3.6 Global Hirudin Production, Value, and Year-over-Year Growth
3.6.1 North America Hirudin Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Hirudin Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Hirudin Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Hirudin Production Value Estimates and Forecasts (2021–2032)
4 Hirudin Consumption by Region
4.1 Global Hirudin Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Hirudin Consumption by Region (2021–2032)
4.2.1 Global Hirudin Consumption by Region (2021–2026)
4.2.2 Global Hirudin Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Hirudin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Hirudin Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Hirudin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Hirudin Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Hirudin Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Hirudin Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Hirudin Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Hirudin Production by Type (2021–2032)
5.1.1 Global Hirudin Production by Type (2021–2026)
5.1.2 Global Hirudin Production by Type (2027–2032)
5.1.3 Global Hirudin Production Market Share by Type (2021–2032)
5.2 Global Hirudin Production Value by Type (2021–2032)
5.2.1 Global Hirudin Production Value by Type (2021–2026)
5.2.2 Global Hirudin Production Value by Type (2027–2032)
5.2.3 Global Hirudin Production Value Market Share by Type (2021–2032)
5.3 Global Hirudin Price by Type (2021–2032)
6 Segment by Application
6.1 Global Hirudin Production by Application (2021–2032)
6.1.1 Global Hirudin Production by Application (2021–2026)
6.1.2 Global Hirudin Production by Application (2027–2032)
6.1.3 Global Hirudin Production Market Share by Application (2021–2032)
6.2 Global Hirudin Production Value by Application (2021–2032)
6.2.1 Global Hirudin Production Value by Application (2021–2026)
6.2.2 Global Hirudin Production Value by Application (2027–2032)
6.2.3 Global Hirudin Production Value Market Share by Application (2021–2032)
6.3 Global Hirudin Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Novartis
7.1.1 Novartis Hirudin Company Information
7.1.2 Novartis Hirudin Product Portfolio
7.1.3 Novartis Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Novartis Main Business and Markets Served
7.1.5 Novartis Recent Developments/Updates
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Hirudin Company Information
7.2.2 Teva Pharmaceuticals Hirudin Product Portfolio
7.2.3 Teva Pharmaceuticals Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Teva Pharmaceuticals Main Business and Markets Served
7.2.5 Teva Pharmaceuticals Recent Developments/Updates
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Hirudin Company Information
7.3.2 Pfizer, Inc Hirudin Product Portfolio
7.3.3 Pfizer, Inc Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Pfizer, Inc Main Business and Markets Served
7.3.5 Pfizer, Inc Recent Developments/Updates
7.4 Pentapharm
7.4.1 Pentapharm Hirudin Company Information
7.4.2 Pentapharm Hirudin Product Portfolio
7.4.3 Pentapharm Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Pentapharm Main Business and Markets Served
7.4.5 Pentapharm Recent Developments/Updates
7.5 DUOPUTAI
7.5.1 DUOPUTAI Hirudin Company Information
7.5.2 DUOPUTAI Hirudin Product Portfolio
7.5.3 DUOPUTAI Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 DUOPUTAI Main Business and Markets Served
7.5.5 DUOPUTAI Recent Developments/Updates
7.6 Abbott
7.6.1 Abbott Hirudin Company Information
7.6.2 Abbott Hirudin Product Portfolio
7.6.3 Abbott Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Abbott Main Business and Markets Served
7.6.5 Abbott Recent Developments/Updates
7.7 Keyken
7.7.1 Keyken Hirudin Company Information
7.7.2 Keyken Hirudin Product Portfolio
7.7.3 Keyken Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Keyken Main Business and Markets Served
7.7.5 Keyken Recent Developments/Updates
7.8 Minapharm
7.8.1 Minapharm Hirudin Company Information
7.8.2 Minapharm Hirudin Product Portfolio
7.8.3 Minapharm Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Minapharm Main Business and Markets Served
7.8.5 Minapharm Recent Developments/Updates
7.9 Salubris Bio
7.9.1 Salubris Bio Hirudin Company Information
7.9.2 Salubris Bio Hirudin Product Portfolio
7.9.3 Salubris Bio Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Salubris Bio Main Business and Markets Served
7.9.5 Salubris Bio Recent Developments/Updates
7.10 Hoechst AG
7.10.1 Hoechst AG Hirudin Company Information
7.10.2 Hoechst AG Hirudin Product Portfolio
7.10.3 Hoechst AG Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Hoechst AG Main Business and Markets Served
7.10.5 Hoechst AG Recent Developments/Updates
7.11 Ciba-Geigy
7.11.1 Ciba-Geigy Hirudin Company Information
7.11.2 Ciba-Geigy Hirudin Product Portfolio
7.11.3 Ciba-Geigy Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Ciba-Geigy Main Business and Markets Served
7.11.5 Ciba-Geigy Recent Developments/Updates
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Hirudin Company Information
7.12.2 Boehringer Ingelheim Hirudin Product Portfolio
7.12.3 Boehringer Ingelheim Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Boehringer Ingelheim Main Business and Markets Served
7.12.5 Boehringer Ingelheim Recent Developments/Updates
7.13 Sanofi
7.13.1 Sanofi Hirudin Company Information
7.13.2 Sanofi Hirudin Product Portfolio
7.13.3 Sanofi Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Sanofi Main Business and Markets Served
7.13.5 Sanofi Recent Developments/Updates
7.14 Xellia Pharmaceuticals
7.14.1 Xellia Pharmaceuticals Hirudin Company Information
7.14.2 Xellia Pharmaceuticals Hirudin Product Portfolio
7.14.3 Xellia Pharmaceuticals Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Xellia Pharmaceuticals Main Business and Markets Served
7.14.5 Xellia Pharmaceuticals Recent Developments/Updates
7.15 Haplogen Pharmaceuticals
7.15.1 Haplogen Pharmaceuticals Hirudin Company Information
7.15.2 Haplogen Pharmaceuticals Hirudin Product Portfolio
7.15.3 Haplogen Pharmaceuticals Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Haplogen Pharmaceuticals Main Business and Markets Served
7.15.5 Haplogen Pharmaceuticals Recent Developments/Updates
7.16 Shenzhen Kangtai Biological
7.16.1 Shenzhen Kangtai Biological Hirudin Company Information
7.16.2 Shenzhen Kangtai Biological Hirudin Product Portfolio
7.16.3 Shenzhen Kangtai Biological Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 Shenzhen Kangtai Biological Main Business and Markets Served
7.16.5 Shenzhen Kangtai Biological Recent Developments/Updates
7.17 Dong-A ST
7.17.1 Dong-A ST Hirudin Company Information
7.17.2 Dong-A ST Hirudin Product Portfolio
7.17.3 Dong-A ST Hirudin Production, Value, Price, and Gross Margin (2021–2026)
7.17.4 Dong-A ST Main Business and Markets Served
7.17.5 Dong-A ST Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Hirudin Industry Chain Analysis
8.2 Hirudin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Hirudin Production Modes and Processes
8.4 Hirudin Sales and Marketing
8.4.1 Hirudin Sales Channels
8.4.2 Hirudin Distributors
8.5 Hirudin Customer Analysis
9 Hirudin Market Dynamics
9.1 Hirudin Industry Trends
9.2 Hirudin Market Drivers
9.3 Hirudin Market Challenges
9.4 Hirudin Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Hirudin Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hirudin Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hirudin Production Capacity (Tons) by Manufacturers in 2025
 Table 4. Global Hirudin Production by Manufacturers (Tons), 2021–2026
 Table 5. Global Hirudin Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Hirudin Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Hirudin Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Hirudin, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hirudin Production Value, 2025
 Table 10. Global Market Hirudin Average Price by Manufacturers (US$/kg), 2021–2026
 Table 11. Global Key Manufacturers of Hirudin, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Hirudin, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Hirudin, Date of Entry into the Industry
 Table 14. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Hirudin Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Hirudin Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Hirudin Production Value Market Share by Region (2021–2026)
 Table 19. Global Hirudin Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Hirudin Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Hirudin Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Hirudin Production (Tons) by Region (2021–2026)
 Table 23. Global Hirudin Production Market Share by Region (2021–2026)
 Table 24. Global Hirudin Production (Tons) Forecast by Region (2027–2032)
 Table 25. Global Hirudin Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Hirudin Market Average Price (US$/kg) by Region (2021–2026)
 Table 27. Global Hirudin Market Average Price (US$/kg) by Region (2027–2032)
 Table 28. Global Hirudin Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 29. Global Hirudin Consumption by Region (Tons), 2021–2026
 Table 30. Global Hirudin Consumption Market Share by Region (2021–2026)
 Table 31. Global Hirudin Forecasted Consumption by Region (Tons), 2027–2032
 Table 32. Global Hirudin Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Hirudin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 34. North America Hirudin Consumption by Country (Tons), 2021–2026
 Table 35. North America Hirudin Consumption by Country (Tons), 2027–2032
 Table 36. Europe Hirudin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 37. Europe Hirudin Consumption by Country (Tons), 2021–2026
 Table 38. Europe Hirudin Consumption by Country (Tons), 2027–2032
 Table 39. Asia Pacific Hirudin Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)
 Table 40. Asia Pacific Hirudin Consumption by Region (Tons), 2021–2026
 Table 41. Asia Pacific Hirudin Consumption by Region (Tons), 2027–2032
 Table 42. Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)
 Table 43. Latin America, Middle East & Africa Hirudin Consumption by Country (Tons), 2021–2026
 Table 44. Latin America, Middle East & Africa Hirudin Consumption by Country (Tons), 2027–2032
 Table 45. Global Hirudin Production (Tons) by Type (2021–2026)
 Table 46. Global Hirudin Production (Tons) by Type (2027–2032)
 Table 47. Global Hirudin Production Market Share by Type (2021–2026)
 Table 48. Global Hirudin Production Market Share by Type (2027–2032)
 Table 49. Global Hirudin Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Hirudin Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Hirudin Production Value Market Share by Type (2021–2026)
 Table 52. Global Hirudin Production Value Market Share by Type (2027–2032)
 Table 53. Global Hirudin Price (US$/kg) by Type (2021–2026)
 Table 54. Global Hirudin Price (US$/kg) by Type (2027–2032)
 Table 55. Global Hirudin Production (Tons) by Application (2021–2026)
 Table 56. Global Hirudin Production (Tons) by Application (2027–2032)
 Table 57. Global Hirudin Production Market Share by Application (2021–2026)
 Table 58. Global Hirudin Production Market Share by Application (2027–2032)
 Table 59. Global Hirudin Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Hirudin Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Hirudin Production Value Market Share by Application (2021–2026)
 Table 62. Global Hirudin Production Value Market Share by Application (2027–2032)
 Table 63. Global Hirudin Price (US$/kg) by Application (2021–2026)
 Table 64. Global Hirudin Price (US$/kg) by Application (2027–2032)
 Table 65. Novartis Hirudin Company Information
 Table 66. Novartis Hirudin Specification and Application
 Table 67. Novartis Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 68. Novartis Main Business and Markets Served
 Table 69. Novartis Recent Developments/Updates
 Table 70. Teva Pharmaceuticals Hirudin Company Information
 Table 71. Teva Pharmaceuticals Hirudin Specification and Application
 Table 72. Teva Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 73. Teva Pharmaceuticals Main Business and Markets Served
 Table 74. Teva Pharmaceuticals Recent Developments/Updates
 Table 75. Pfizer, Inc Hirudin Company Information
 Table 76. Pfizer, Inc Hirudin Specification and Application
 Table 77. Pfizer, Inc Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 78. Pfizer, Inc Main Business and Markets Served
 Table 79. Pfizer, Inc Recent Developments/Updates
 Table 80. Pentapharm Hirudin Company Information
 Table 81. Pentapharm Hirudin Specification and Application
 Table 82. Pentapharm Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 83. Pentapharm Main Business and Markets Served
 Table 84. Pentapharm Recent Developments/Updates
 Table 85. DUOPUTAI Hirudin Company Information
 Table 86. DUOPUTAI Hirudin Specification and Application
 Table 87. DUOPUTAI Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 88. DUOPUTAI Main Business and Markets Served
 Table 89. DUOPUTAI Recent Developments/Updates
 Table 90. Abbott Hirudin Company Information
 Table 91. Abbott Hirudin Specification and Application
 Table 92. Abbott Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 93. Abbott Main Business and Markets Served
 Table 94. Abbott Recent Developments/Updates
 Table 95. Keyken Hirudin Company Information
 Table 96. Keyken Hirudin Specification and Application
 Table 97. Keyken Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 98. Keyken Main Business and Markets Served
 Table 99. Keyken Recent Developments/Updates
 Table 100. Minapharm Hirudin Company Information
 Table 101. Minapharm Hirudin Specification and Application
 Table 102. Minapharm Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 103. Minapharm Main Business and Markets Served
 Table 104. Minapharm Recent Developments/Updates
 Table 105. Salubris Bio Hirudin Company Information
 Table 106. Salubris Bio Hirudin Specification and Application
 Table 107. Salubris Bio Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 108. Salubris Bio Main Business and Markets Served
 Table 109. Salubris Bio Recent Developments/Updates
 Table 110. Hoechst AG Hirudin Company Information
 Table 111. Hoechst AG Hirudin Specification and Application
 Table 112. Hoechst AG Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 113. Hoechst AG Main Business and Markets Served
 Table 114. Hoechst AG Recent Developments/Updates
 Table 115. Ciba-Geigy Hirudin Company Information
 Table 116. Ciba-Geigy Hirudin Specification and Application
 Table 117. Ciba-Geigy Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 118. Ciba-Geigy Main Business and Markets Served
 Table 119. Ciba-Geigy Recent Developments/Updates
 Table 120. Boehringer Ingelheim Hirudin Company Information
 Table 121. Boehringer Ingelheim Hirudin Specification and Application
 Table 122. Boehringer Ingelheim Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 123. Boehringer Ingelheim Main Business and Markets Served
 Table 124. Boehringer Ingelheim Recent Developments/Updates
 Table 125. Sanofi Hirudin Company Information
 Table 126. Sanofi Hirudin Specification and Application
 Table 127. Sanofi Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 128. Sanofi Main Business and Markets Served
 Table 129. Sanofi Recent Developments/Updates
 Table 130. Xellia Pharmaceuticals Hirudin Company Information
 Table 131. Xellia Pharmaceuticals Hirudin Specification and Application
 Table 132. Xellia Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 133. Xellia Pharmaceuticals Main Business and Markets Served
 Table 134. Xellia Pharmaceuticals Recent Developments/Updates
 Table 135. Haplogen Pharmaceuticals Hirudin Company Information
 Table 136. Haplogen Pharmaceuticals Hirudin Specification and Application
 Table 137. Haplogen Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 138. Haplogen Pharmaceuticals Main Business and Markets Served
 Table 139. Haplogen Pharmaceuticals Recent Developments/Updates
 Table 140. Shenzhen Kangtai Biological Hirudin Company Information
 Table 141. Shenzhen Kangtai Biological Hirudin Specification and Application
 Table 142. Shenzhen Kangtai Biological Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 143. Shenzhen Kangtai Biological Main Business and Markets Served
 Table 144. Shenzhen Kangtai Biological Recent Developments/Updates
 Table 145. Dong-A ST Hirudin Company Information
 Table 146. Dong-A ST Hirudin Specification and Application
 Table 147. Dong-A ST Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
 Table 148. Dong-A ST Main Business and Markets Served
 Table 149. Dong-A ST Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Hirudin Distributors List
 Table 153. Hirudin Customers List
 Table 154. Hirudin Market Trends
 Table 155. Hirudin Market Drivers
 Table 156. Hirudin Market Challenges
 Table 157. Hirudin Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hirudin
 Figure 2. Global Hirudin Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hirudin Market Share by Type: 2025 vs 2032
 Figure 4. Natural Hirudin Product Picture
 Figure 5. Recombinant Hirudin Product Picture
 Figure 6. Global Hirudin Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Hirudin Market Share by Application: 2025 vs 2032
 Figure 8. Thrombosis Disease
 Figure 9. Tumor Disease
 Figure 10. Others
 Figure 11. Global Hirudin Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Hirudin Production Value (US$ Million), 2021–2032
 Figure 13. Global Hirudin Production Capacity (Tons), 2021–2032
 Figure 14. Global Hirudin Production (Tons), 2021–2032
 Figure 15. Global Hirudin Average Price (US$/kg), 2021–2032
 Figure 16. Hirudin Report Years Considered
 Figure 17. Hirudin Production Share by Manufacturers in 2025
 Figure 18. Global Hirudin Production Value Share by Manufacturers (2025)
 Figure 19. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Top 5 and Top 10 Global Players: Market Share by Hirudin Revenue in 2025
 Figure 21. Global Hirudin Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 22. Global Hirudin Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 23. Global Hirudin Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 24. Global Hirudin Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 25. North America Hirudin Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 26. Europe Hirudin Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 27. China Hirudin Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 28. Japan Hirudin Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 29. Global Hirudin Consumption by Region: 2021 vs 2025 vs 2032 (Tons)
 Figure 30. Global Hirudin Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 31. North America Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 32. North America Hirudin Consumption Market Share by Country (2021–2032)
 Figure 33. U.S. Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 34. Canada Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 35. Europe Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 36. Europe Hirudin Consumption Market Share by Country (2021–2032)
 Figure 37. Germany Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 38. France Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 39. U.K. Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 40. Italy Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 41. Russia Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 42. Asia Pacific Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 43. Asia Pacific Hirudin Consumption Market Share by Region (2021–2032)
 Figure 44. China Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 45. Japan Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 46. South Korea Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 47. China Taiwan Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 48. Southeast Asia Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 49. India Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 50. Latin America, Middle East & Africa Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 51. Latin America, Middle East & Africa Hirudin Consumption Market Share by Country (2021–2032)
 Figure 52. Mexico Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 53. Brazil Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 54. Turkey Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 55. GCC Countries Hirudin Consumption and Growth Rate (Tons), 2021–2032
 Figure 56. Global Production Market Share of Hirudin by Type (2021–2032)
 Figure 57. Global Production Value Market Share of Hirudin by Type (2021–2032)
 Figure 58. Global Hirudin Price (US$/kg) by Type (2021–2032)
 Figure 59. Global Production Market Share of Hirudin by Application (2021–2032)
 Figure 60. Global Production Value Market Share of Hirudin by Application (2021–2032)
 Figure 61. Global Hirudin Price (US$/kg) by Application (2021–2032)
 Figure 62. Hirudin Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI